Strategic Collaborations Leverage HRI’s extensive network of over 110 collaborations across 44 countries and key partnerships with the Charles Perkins Centre, Royal Prince Alfred Hospital, Sydney Local Health District and Sydney Health Partners to identify co-development, grant-funded research, and contract research opportunities.

Funding Momentum Target HRI’s recent and ongoing funding activity, including NHMRC grants of over 4.3M and broad research programs in cardiovascular diseases, to propose sponsored research, technology licensing, and clinical translation partnerships that align with their funding cycles.

Clinical Translation Position services around accelerating bench-to-bedside outcomes by offering drug discovery, device development, and translational research platforms that align with HRI’s mission to translate research into clinical trials and new therapies.

Leadership & Talent Engage through leadership-driven initiatives and upcoming capabilities by aligning with newly appointed Deputy Director and Director of Research and specialist hires to present advanced collaborative research programs, pilot projects, and knowledge transfer opportunities.

Expansion & Visibility Capitalize on growth signals such as the new Centre for Peripheral Artery Disease and international ambassador activities to offer targeted education programs, patient awareness tools, and digital outreach services that amplify research impact and attract sponsorships.